+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Chronic Kidney Disease Market - Global Forecast 2026-2032- Product Image
Chronic Kidney Disease Market - Global Forecast 2026-2032- Product Image
New

Chronic Kidney Disease Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 195 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5977705
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The chronic kidney disease market is rapidly evolving as new diagnostics, therapies, and care models reshape treatment landscapes and operational priorities for healthcare stakeholders. Senior leaders are seeking reliable market intelligence to support robust decision-making and investment strategies in this complex sector.

Market Snapshot: Chronic Kidney Disease Market

The Chronic Kidney Disease Market was valued at USD 145.75 billion in 2025 and is projected to reach USD 154.70 billion in 2026. The market is expected to expand at a CAGR of 6.70%, with forecasts indicating a total market size of USD 229.64 billion by 2032. This substantial growth is driven by increased emphasis on early detection, integrated care, and technological advancements across diagnostics, therapeutics, and care settings.

Scope & Segmentation

  • Therapy Types: Diagnostics (imaging and laboratory), dialysis (hemodialysis and peritoneal dialysis), pharmaceuticals (including antihypertensives, erythropoietin-stimulating agents, iron supplements, phosphate binders), and transplantation.
  • Disease Stages: Early, moderate, severe, and end-stage renal disease, each with evolving care priorities from risk mitigation to replacement therapies.
  • Care Settings: Ambulatory clinics, dialysis centers, home care, and hospitals, each demanding tailored operational models and clinical resources.
  • Product Types: Consumables (catheters, needles, filters, dialyzers), equipment (hemodialysis machines, peritoneal dialysis cyclers), and monitoring devices (blood testing devices, imaging systems).
  • Patient Demographics: Distinction between adult and pediatric populations, informing dosing, device selection, and care coordination strategies.
  • Regions Covered: Americas, Europe, Middle East & Africa, and Asia-Pacific, each with distinctive regulatory, commercial, and infrastructure dynamics.

Key Takeaways for Senior Decision-Makers

  • Early detection solutions and risk stratification technologies are increasingly relied upon to optimize care pathways, offering new avenues for intervention and monitoring.
  • The shift to home-based care and remote monitoring is prompting investment in patient-centered models, requiring device adaptation and new digital engagement approaches.
  • Regulatory and reimbursement reforms are accelerating demand for evidence-based solutions and outcome-driven payment models, guiding product development and clinical evidence strategy.
  • Supply chain resilience—through sourcing diversification and manufacturing localization—has become critical as global disruptions and tariff policies elevate procurement considerations.
  • Regional markets require tailored strategies to navigate differing payer structures, regulatory landscapes, and infrastructure maturity, particularly in rapidly progressing Asia-Pacific countries.
  • Strategic collaborations among device makers, pharmaceutical firms, and technology entrants are enhancing competitive positioning by integrating expertise across clinical and operational domains.

Tariff Impact on the Chronic Kidney Disease Market

Recent tariff adjustments in the United States introduce significant implications for procurement and supply chain management. Duties on imported equipment and pharmaceutical components are expected to increase acquisition costs for dialysis providers. In response, stakeholders are exploring local manufacturing, strategic partnerships, and sourcing diversification to protect cost structures and ensure continuity. Providers may also seek to renegotiate contracts and standardize equipment lifecycles, while regulatory compliance is further emphasized as product configurations adapt to changing requirements.

Methodology & Data Sources

This analysis leverages a mixed-methods research approach combining structured interviews with clinicians, payers, procurement leaders, and regulatory experts, alongside comprehensive clinical literature review and product portfolio analysis. The report integrates primary insights with validated secondary sources to support actionable, unbiased recommendations.

Why This Report Matters

  • Enables executives to anticipate shifting regulatory and reimbursement trends by mapping out the interplay of diagnostics, devices, and supply chain strategies.
  • Identifies high-impact opportunities for product development, market entry, and operational partnerships, grounded in granular segmentation and regional analysis.
  • Equips decision-makers to develop agile, evidence-led strategies capable of withstanding trade disruptions and supporting patient outcomes.

Conclusion

Chronic kidney disease management is undergoing transformative change. Leaders who align clinical, operational, and commercial insights will be best placed to seize opportunities, mitigate risks, and drive improved outcomes. Strategic execution, robust data, and collaboration across the care continuum are essential for market success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Chronic Kidney Disease Market, by Therapy Type
8.1. Diagnostics
8.1.1. Imaging Diagnostics
8.1.2. Laboratory Diagnostics
8.2. Dialysis
8.2.1. Hemodialysis
8.2.2. Peritoneal Dialysis
8.3. Pharmaceuticals
8.3.1. Antihypertensives
8.3.2. Erythropoietin Stimulating Agents
8.3.2.1. Darbepoetin Alfa
8.3.2.2. Epoetin Alfa
8.3.3. Iron Supplements
8.3.4. Phosphate Binders
8.4. Transplantation
9. Chronic Kidney Disease Market, by Disease Stage
9.1. Early Disease
9.2. End Stage Renal Disease
9.3. Moderate Disease
9.4. Severe Disease
10. Chronic Kidney Disease Market, by End User
10.1. Ambulatory Care Clinic
10.2. Dialysis Center
10.3. Home Care
10.4. Hospital
11. Chronic Kidney Disease Market, by Product
11.1. Consumables
11.1.1. Catheters & Needles
11.1.2. Filters & Dialyzers
11.2. Equipment
11.2.1. Hemodialysis Machine
11.2.2. Peritoneal Dialysis Cycler
11.3. Monitoring Devices
11.3.1. Blood Testing Devices
11.3.2. Imaging Systems
12. Chronic Kidney Disease Market, by Patient Type
12.1. Adult
12.2. Pediatric
13. Chronic Kidney Disease Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Chronic Kidney Disease Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Chronic Kidney Disease Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Chronic Kidney Disease Market
17. China Chronic Kidney Disease Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AbbVie Inc.
18.6. Allmed Medical Products Co., Ltd.
18.7. AngioDynamics, Inc.
18.8. Apotex Inc.
18.9. Asahi Kasei Corporation
18.10. AstraZeneca PLC
18.11. B. Braun SE
18.12. Baxter International, Inc.
18.13. Becton, Dickinson and Company
18.14. Centessa Pharmaceuticals Limited
18.15. DaVita Inc.
18.16. Dialife SA
18.17. Dr. Reddys Laboratories Ltd.
18.18. Evoqua Water Technologies LLC
18.19. Fresenius Medical Care AG
18.20. Galapagos NV
18.21. Hemoclean Co. Ltd.
18.22. JMS Co., Ltd.
18.23. Johnson & Johnson Services, Inc.
18.24. Medtronic PLC
18.25. Merck & Co., Inc.
18.26. Nikkiso Co., Ltd.
18.27. Nipro Corporation
18.28. Novartis AG
18.29. NxStage Medical Inc.
18.30. Otsuka Pharmaceutical Co., Ltd.
18.31. Reata Pharmaceuticals Inc.
18.32. Rockwell Medical Inc.
18.33. Sanofi S.A.
18.34. Teva Pharmaceutical Industries Ltd.
18.35. Toray Medical Co., Ltd.
18.36. Trivitron Healthcare
18.37. XORTX Therapeutics Inc.
List of Figures
FIGURE 1. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CHRONIC KIDNEY DISEASE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CHRONIC KIDNEY DISEASE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IMAGING DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IMAGING DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IMAGING DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ANTIHYPERTENSIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ANTIHYPERTENSIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ANTIHYPERTENSIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DARBEPOETIN ALFA, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DARBEPOETIN ALFA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DARBEPOETIN ALFA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EPOETIN ALFA, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EPOETIN ALFA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EPOETIN ALFA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IRON SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IRON SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IRON SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHOSPHATE BINDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHOSPHATE BINDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHOSPHATE BINDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EARLY DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EARLY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EARLY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END STAGE RENAL DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END STAGE RENAL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END STAGE RENAL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MODERATE DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MODERATE DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MODERATE DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY SEVERE DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY SEVERE DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY SEVERE DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY AMBULATORY CARE CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY AMBULATORY CARE CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY AMBULATORY CARE CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS CENTER, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS CENTER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CATHETERS & NEEDLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CATHETERS & NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CATHETERS & NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY FILTERS & DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY FILTERS & DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY FILTERS & DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HEMODIALYSIS MACHINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HEMODIALYSIS MACHINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HEMODIALYSIS MACHINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS CYCLER, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS CYCLER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS CYCLER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY BLOOD TESTING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY BLOOD TESTING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY BLOOD TESTING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 166. EUROPE CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. EUROPE CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 168. EUROPE CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 169. EUROPE CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 170. EUROPE CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 171. EUROPE CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 172. EUROPE CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 173. EUROPE CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 174. EUROPE CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 175. EUROPE CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 176. EUROPE CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 177. EUROPE CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 178. EUROPE CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 192. AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 194. AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 195. AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 196. AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 197. AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 198. AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 199. AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 201. AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 202. AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 203. AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 204. AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 218. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 219. ASEAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. ASEAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 221. ASEAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 222. ASEAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 223. ASEAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 224. ASEAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 225. ASEAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 226. ASEAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. ASEAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 228. ASEAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 229. ASEAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 230. ASEAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 231. ASEAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 232. GCC CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 233. GCC CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 234. GCC CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 235. GCC CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 236. GCC CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 237. GCC CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 238. GCC CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 239. GCC CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. GCC CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 241. GCC CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 242. GCC CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 243. GCC CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 244. GCC CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 258. BRICS CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. BRICS CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 260. BRICS CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 261. BRICS CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 262. BRICS CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 263. BRICS CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 264. BRICS CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 265. BRICS CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 266. BRICS CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 267. BRICS CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 268. BRICS CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 269. BRICS CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 270. BRICS CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 271. G7 CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 272. G7 CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 273. G7 CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 274. G7 CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 275. G7 CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 276. G7 CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 277. G7 CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 278. G7 CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 279. G7 CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 280. G7 CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 281. G7 CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 282. G7 CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 283. G7 CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 284. NATO CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 285. NATO CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 286. NATO CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 287. NATO CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 288. NATO CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 289. NATO CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 290. NATO CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 291. NATO CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 292. NATO CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 293. NATO CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 294. NATO CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 295. NATO CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 296. NATO CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 297. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 298. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 299. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 300. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 301. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 302. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 303. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 304. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 305. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 306. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 307. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 308. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 309. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 310. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 311. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 312. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 313. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 314. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2032 (USD MILLION)
TABLE 315. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 316. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2032 (USD MILLION)
TABLE 317. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 318. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 319. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 320. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 321. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 322. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 323. CHINA CHRONIC KIDNEY DISEASE MARKET

Companies Mentioned

The key companies profiled in this Chronic Kidney Disease market report include:
  • AbbVie Inc.
  • Allmed Medical Products Co., Ltd.
  • AngioDynamics, Inc.
  • Apotex Inc.
  • Asahi Kasei Corporation
  • AstraZeneca PLC
  • B. Braun SE
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Centessa Pharmaceuticals Limited
  • DaVita Inc.
  • Dialife SA
  • Dr. Reddys Laboratories Ltd.
  • Evoqua Water Technologies LLC
  • Fresenius Medical Care AG
  • Galapagos NV
  • Hemoclean Co. Ltd.
  • JMS Co., Ltd.
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Merck & Co., Inc.
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Novartis AG
  • NxStage Medical Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Reata Pharmaceuticals Inc.
  • Rockwell Medical Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Toray Medical Co., Ltd.
  • Trivitron Healthcare
  • XORTX Therapeutics Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 154.7 Billion
Forecasted Market Value ( USD ) by 2032 $ 229.64 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned34

Related Topics

Related Reports

Chronic Kidney Disease Treatment Market - Global Strategic Business Report - Product Image

Chronic Kidney Disease Treatment Market - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Chronic Kidney Disease Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Chronic Kidney Disease Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Kidney Disease Market Report 2025 - Product Image

Kidney Disease Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Chronic Kidney Disease Market Report 2025 - Product Image

Chronic Kidney Disease Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Clinical Nutrition for Chronic Kidney Diseases Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Clinical Nutrition for Chronic Kidney Diseases Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.